Why the study?
Does an elevated preoperative NT-proBNP level predict the need for inotropic support in patients undergoing coronary artery bypass graft surgery?
Does an elevated preoperative NT-proBNP level predict the need for inotropic support in patients undergoing coronary artery bypass graft surgery?
Preoperative NT-proBNP levels >220 pg/ml can predict the need for prolonged and higher-dose inotropic support after coronary artery bypass graft surgery.
BACKGROUND: The aim of this study was to evaluate the relationship between the preoperative N-terminal pro-B-type natriuretic peptide (NT-proBNP) level and the need for the inotropic support in the early postoperative period of patients undergoing coronary artery bypass graft surgery. METHODS AND RESULTS: The patients were divided into 2 groups: NT-proBNP level<220 pg/ml (group A, n=26) or >220 pg/ml (group B, n=26). The normal value for NT-proBNP level was accepted as <220 pg/ml. The cardiac output was measured on arrival in intensive care and at the 16th hour. The groups were compared with respect to early postoperative hemodynamic measurements, urinary output, use of inotropic agents and requirement for additional cardiac-assist devices. Left ventricular ejection fraction, cardiac output and cardiac index were lower in group B and inotropic agents were used for a longer period of time and at higher doses in this group (p<0.05). CONCLUSION: Measurement of the NT-proBNP level in the period before cardiac surgery can indicate the postoperative prognosis of the patient and may be a predictor of the need for postoperative inotropic treatment.
No takes yet. Share an insight, caveat, or question.
Cerrahoğlu et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: